We are investigating how well Durvalumab works for patients with non-small cell lung cancer after they receive chemotherapy and radiation. This study includes both PDL1 positive and negative patients to see how their responses differ.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in the lungs. It is the most common form of lung cancer and can lead to symptoms such as persistent cough, chest pain, and difficulty breathing.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
